U.S. pharmaceutical giant Pfizer is to offer its pneumonia vaccine at a much lower price to NGOs working on humanitarian crises.
The drug company said a new multidose version of its Prevenar 13 vaccine will be available at $3.10 per dose, the “lowest prevailing global” price, to select groups working in emergency settings, starting early next year. In the meantime, Pfizer will offer free single-dose vials of the drug to NGOs to address immediate needs for the vaccine in disaster settings.
Pneumonia killed 920,000 children worldwide in 2015, according to the World Health Organization.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Sophie Edwards
Sophie Edwards is a Devex Contributing Reporter covering global education, water and sanitation, and innovative financing, along with other topics. She has previously worked for NGOs, and the World Bank, and spent a number of years as a journalist for a regional newspaper in the U.K. She has a master's degree from the Institute of Development Studies and a bachelor's from Cambridge University.